Ovid Therapeutics Inc.
OVID
Revenue
6.27M
▲6.14M▲4724.62%
3 Months ChangeAssets
77.43M
▼-4.23M▼-5.18%
3 Months ChangeLiabilities
21.64M
▼-738.00k▼-3.30%
3 Months ChangeFree Cash Flow
-10.28M
▲6.43M▲38.46%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-11
Form 8-K
ID: 0001193125-24-217302
2024-08-13
Form 10-Q
ID: 0001628280-24-036860
2024-08-13
Form 8-K
ID: 0001628280-24-036859
2024-08-02
Form 8-K
ID: 0001628280-24-034481
2024-07-01
Form 8-K
ID: 0001628280-24-030546
2024-06-28
Form 8-K
ID: 0001193125-24-172225
2024-06-17
Form 8-K
ID: 0000950170-24-073998
2024-06-07
Form 8-K
ID: 0000950170-24-070673
2024-05-14
Form 10-Q
ID: 0001628280-24-023067
2024-05-14
Form 8-K
ID: 0001628280-24-023064